Fine-Mapping the Genetic Association of the Major Histocompatibility Complex in Multiple Sclerosis: HLA and Non-HLA Effects
Creators
- Patsopoulos, Nikolaos A.1
- Barcellos, Lisa F.2
- Hintzen, Rogier Q.3
- Schaefer, Catherine4
- Duijn, Cornelia M. van3
- Noble, Janelle A.5
- Raj, Towfique1
- IMSGC
- ANZgene
- Gourraud, Pierre-Antoine6
- Stranger, Barbara E.7
- Oksenberg, Jorge8
- Olsson, Tomas9
- Taylor, Bruce V.10
- Sawcer, Stephen11
- Hafler, David A.12
- Carrington, Mary13
- Jager, Philip L. De1
- 1. Harvard University
- 2. University of California, Berkeley
- 3. Erasmus MC
- 4. Kaiser Permanente
- 5. Children's Hospital Oakland Research Institute
- 6. University of California San Francisco
- 7. University of Chicago
- 8. University of California at San Francisco
- 9. Karolinska Institutet
- 10. University of Tasmania
- 11. University of Cambridge
- 12. Yale University
- 13. Frederick National Laboratory for Cancer Research
Description
The major histocompatibility complex (MHC) region is strongly associated with multiple sclerosis (MS) susceptibility. HLA-DRB1*15:01 has the strongest effect, and several other alleles have been reported at different levels of validation. Using SNP data from genome-wide studies, we imputed and tested classical alleles and amino acid polymorphisms in 8 classical human leukocyte antigen (HLA) genes in 5,091 cases and 9,595 controls. We identified 11 statistically independent effects overall: 6 HLA-DRB1 and one DPB1 alleles in class II, one HLA-A and two B alleles in class I, and one signal in a region spanning from MICB to LST1. This genomic segment does not contain any HLA class I or II genes and provides robust evidence for the involvement of a non-HLA risk allele within the MHC. Interestingly, this region contains the TNF gene, the cognate ligand of the well-validated TNFRSF1A MS susceptibility gene. The classical HLA effects can be explained to some extent by polymorphic amino acid positions in the peptide-binding grooves. This study dissects the independent effects in the MHC, a critical region for MS susceptibility that harbors multiple risk alleles.
Files
journal.pgen.1003926.pdf
Files
(3.7 MB)
| Name | Size | Download all |
|---|---|---|
|
Article md5:0f60af0d21269bdbeda512993d2eeab5 |
996.4 kB | Preview Download |
|
md5:8cd2a205f96ec23eea6d8770f1a7f1ee
|
2.7 MB | Preview Download |
Additional details
Identifiers
- DOI
- 10.1371/journal.pgen.1003926
- Other
- oai:uchicago.tind.io:10755
Funding
- National Multiple Sclerosis Society
- Postdoctoral Fellowship
- Unknown funder
- R01NS049477
- Unknown funder
- R01NS026799
- National Institute of Neurological Disorders and Stroke
- R01NS049510
- National Institute of Neurological Disorders and Stroke
- R01NS0495103
- National Institute of Allergy and Infectious Diseases
- R01AI076544
- Dutch MS Research foundation
- Bibbi and Niels Jensens Foundation
- The Swedish Brain Foundation and Swedish research council
- Stockholm County Council
- 562183
- Swedish Council for Working life and Social Research
- Knut and Alice Wallenbergs foundation
- MS research Australia
- John T. Reid Charitable Trusts
- Trish MS Research Foundation and the Australian Research Council
- Linkage Projects Scheme
- National Institute for Health and Care Research
- Frederick National Laboratory for Cancer Research
- HHSN261200800001E
- National Institutes of Health
- Intramural Research Program
- Frederick National Lab
- National MS Society
- Harry Weaver neuroscience scholar
- Netherlands Organization for Scientific Research
- VIDI Award